International Journal of Diabetes & Metabolic Disorders(IJDMD)

Faculty of Medicine and Health Sciences, School of Health Sciences, University of Nottingham, Clifton Boulevard, Nottingham, United Kingdom

Publications

• Research Article   
  The Ability of Combination Sulfonylurea and Metformin in Reducing Morbidity and Mortality in Type 2 Diabetes
  Author(s): Katie Fletcher, Andrew Meal and Gary G. Adams*
  
  Background Literature: Type 2 diabetes is a health concern worldwide, and treatment with oral antidiabetic medicines presents a clinical challenge. This systematic review aims to assess the ability of combination sulfonylurea and metformin in reducing morbidity and mortality in type 2 diabetes. Methods A search of the databases NU Search, PubMed, Ovid, Embase, CINAHL and Medline was conducted by the author, using key search terms. 11 studies were included, 6 RCT’s, and 5 cohort studies with a combined number of 168,138 participants. Results Cardiovascular risk: Atherosclerotic Cardiovascular Disease (ASCVD) risk score DPP4i and metformin: -1.5 versus -1.1 for SU and metformin. Six studies found no difference for MI, CVD, stroke across groups for SU, DPP4i, or SGLT2i. DPP4i combination was superior, with .. Read More»
  

  Abstract HTML PDF